Barinthus Biotherapeutics Pte Ltd. (BRNS) at a glance

Barinthus Biotherapeutics Pte Ltd. (BRNS) is a micro-cap Healthcare company. It trades at $0.72, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 50/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Momentum (18/100). It is a relatively defensive holding with below-market volatility.

Price

$0.72

Market cap

$27.4M

P/E ratio

n/a

Dividend yield

None

Beta

-0.40

52-week range

$0.51 to $2.92